Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Myelodysplastic Syndromes 97Leukemia 94Leukemia, Myeloid, Acute 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Lymphoma 65Leukemia, Lymphocytic, Chronic, B-Cell 61Lymphoma, Non-Hodgkin 56Multiple Myeloma 55Hodgkin Disease 51Leukemia, Myeloid, Chronic-Phase 48Myeloproliferative Disorders 47Leukemia, Myeloid, Accelerated Phase 45Lymphoma, Follicular 43Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 42Lymphoma, B-Cell, Marginal Zone 41Congenital Abnormalities 40Burkitt Lymphoma 40Neoplasms, Plasma Cell 38Lymphoma, Large-Cell, Immunoblastic 35Graft vs Host Disease 32Blast Crisis 32Leukemia, Myelomonocytic, Chronic 30Primary Myelofibrosis 29Anemia, Refractory, with Excess of Blasts 29Dendritic Cell Sarcoma, Interdigitating 28Recurrence 27Myelodysplastic-Myeloproliferative Diseases 26Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Malignant Neoplasm × Antilymphocyte Serum × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡